Friedreich Ataxia Global Clinical Consortium UNIFIED Natural History Study
ConditionFriedreich Ataxia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorFriedreich's Ataxia Research Alliance
About this trial
This project is a global, multicenter, prospective, longitudinal, observational natural history study that can be used to understand the disease progression and support the development of safe and effective drugs and biological products for Friedreich ataxia.
Eligibility criteria
Qualifiers
Both males and females of any age
Individuals with Friedreich ataxia (FA): Participants that meet genetically confirmed diagnosis of Friedreich ataxia
Written informed consent provided
Informed consent must be obtained for all participants
Disqualifiers
Unable or unwilling to provide informed consent
Acute or ongoing medical or other conditions that would interfere with the conduct and assessments of the study
For any reason in the opinion of the investigator, participant would be unlikely or unable to comply with study protocol requirements.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov